Cobiomic is a spin-off from the Institute of Biomedicine of Córdoba, founded by several Ramón y Cajal researchers. The company has pioneered a cutting-edge biomarker identification technology in Spain. With just one microliter of any sample type, they analyze hundreds of protein biomarkers using qPCR.

Currently, this technology has been featured in over 2,000 publications (Nature, Cell, Science, etc.) and has already been used to analyze more than 10,000 samples from Spain’s leading research institutes, hospitals, and the pharmaceutical industry, including Lilly, UCB, Almirall, the University of Navarra, Fundación Jiménez Díaz, and others.